Improving Transparency to Lower Drug Costs Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 1, 2021)
Improving Transparency to Lower Drug Costs Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.
What just happenedJun 2, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 1, 2021
- Jun 2, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 1, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 1, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jun 1, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jun 1, 2021IntroReferralIntro-H
Introduced in House
- Jun 1, 2021IntroReferral1000
Introduced in House